["{\n\"step_by_step_thinking\": \"Given the patient's symptoms of burning chest pain, which is concentrated around his epigastric region following food ingestion, and alleviated by antacids, it suggests that the mechanism of action of the new medication is related to reducing acid production in the stomach. The patient already takes cimetidine (an H2-receptor antagonist) which initially improved his GERD symptoms, but the recent increase in chest pain frequency suggests that he may have developed resistance to this medication. Therefore, a medication with a different mechanism of action would be needed. Among the given options, B: Irreversible inhibition of H+/K+-ATPase at parietal cells is the most likely, as it targets the source of acid production in the stomach.\",\n\"answer_choice\": \"B\""]